Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2011; 17(11): 1501-1506
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1501
Figure 1
Figure 1 Immunohistochemistry staining of gastric carcinoma tissue samples showing negative HER-2 protein expression (A, B), positive HER-2 protein expression (C, D) (original magnification × 200).
Figure 2
Figure 2 Fluorescence in situ hybridization targeting HER-2 in gastric carcinoma specimens showing intestinal type of carcinoma without HER-2 gene amplification (A) and intestinal type of carcinoma with HER-2 gene amplification (B) (original magnification × 1000).